cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease: Cell Reports A Potent and Specific CD38
A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline: Cell Metabolism Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target US20200102274A1 Quinoline derived small molecule inhibitors of nicotinamide n methyltransferase (nnmt) and uses thereof Google Patents Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12





